RT Journal Article
SR Electronic
T1 Protection against Omicron conferred by mRNA primary vaccine series, boosters, and prior infection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.05.26.22275639
DO 10.1101/2022.05.26.22275639
A1 Elizabeth T. Chin
A1 David Leidner
A1 Lauren Lamson
A1 Kimberley Lucas
A1 David M. Studdert
A1 Jeremy D. Goldhaber-Fiebert
A1 Jason R. Andrews
A1 Joshua A. Salomon
YR 2022
UL http://medrxiv.org/content/early/2022/05/27/2022.05.26.22275639.abstract
AB Background Prisons and jails are high-risk settings for Covid-19 transmission, morbidity, and mortality. We evaluate protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system.Methods We employed a test-negative design to match resident and staff cases during the Omicron wave (December 24, 2021—April 14, 2022) to controls according to a case’s test-week as well as demographic, clinical, and carceral characteristics. We estimated protection against infection using conditional logistic regression, with exposure status defined by vaccination, stratified by number of mRNA doses received, and prior infection, stratified by periods before or during Delta variant predominance.Results We matched 15,783 resident and 8,539 staff cases to 180,169 resident and 90,409 staff controls. Among cases, 29.7% and 2.2% were infected before or during the emergence of the Delta variant, respectively; 30.6% and 36.3% were vaccinated with two or three doses, respectively. Estimated protection from Omicron infection for two and three doses were 14.9% (95% Confidence Interval [CI], 12.3—19.7%) and 43.2% (42.2—47.4%) for those without known prior infections, 47.8% (95% CI, 46.6—52.8%) and 61.3% (95% CI, 60.7—64.8%) for those infected before the emergence of Delta, and 73.1% (95% CI, 69.8—80.1%) and 86.8% (95% CI, 82.1—92.7) for those infected during the period of Delta predominance.Conclusion A third mRNA dose provided significant, additional protection over two doses, including among individuals with prior infection. Our findings suggest that vaccination should remain a priority—even in settings with high levels of transmission and prior infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported in part by the Covid-19 Emergency Response Fund at Stanford, established with a gift from the Horowitz Family Foundation; the National Institute on Drug Abuse at the National Institutes of Health [R37-DA15612]; the Centers for Disease Control and Prevention through the Council of State and Territorial Epidemiologists [NU38OT000297-02]; the National Science Foundation Graduate Research Fellowship Program [DGE-1656518].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional review board at Stanford University (protocol #55835).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData not available due to Data Use Agreement between Stanford University and the California Department of Corrections and Rehabilitation.